Diabetes Forecast

The Healthy Living Magazine

Jardiance May Slow Kidney Disease Development

By Miriam E. Tucker , ,


New findings from last year’s study on the type 2 drug empagliflozin (Jardiance), which showed a benefit against heart disease, now reveal yet another advantage: The drug slows the development of kidney disease by 39 percent in people with type 2 diabetes at high risk for heart problems. About a third of people with diabetes develop some degree of kidney damage, so prevention is key. While metformin is still recommended as the first drug to treat type 2 diabetes, this new information may help doctors decide which drug to prescribe next for patients who need more help in achieving their glucose targets.
Source: The New England Journal of Medicine, published online June 14, 2016 


Get Free Health Tips

Register for free recipes, news you can use, and simple health tips – delivered right to your inbox.

Get to Know

While she’s still spinning music, DJ Spinderella (aka Deidra Roper) is no longer spinning her wheels when it comes to getting the right information to help her family members who have diabetes. Read more >